Drugs / Testogel
Testogel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01786473 | Dec 2012 → Dec 2014 | hypogonadism | Laboratoires Besins International | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Testogel | “Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism” NCT01786473 ↗ |
| Known as | Testogel 1% | “Testogel 1% 5g QD” NCT01786473 ↗ |
| Known as | Testosterone Gel | “Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism” NCT01786473 ↗ |
| Action | Restore | “treatment aims to restore testosterone levels to normal physiological range” NCT01786473 ↗ |